Buscar

01/02/2026 Summary of the European Association of Urology/European Society of paediatric urology guidelines on transition in urology
Skott, M, Gnech, M, Bujons, A, Hoen, L, Burgu, B, Rawashdeh, YF, Bogaert, G, Quaedackers, J, Pakkasjärvi, N, Van Uitert, A, Kennedy, U, Yuan, YH, Radmayr, C, Castagnetti, M, O'Kelly, F. Summary of the European Association of Urology/European Society of paediatric urology guidelines on transition in urology. Journal of Pediatric Urology. 2026; 22(1)DOI:10.1016/j.jpurol.2025.10.002. PMID:41203536. IF:1.900(Q2/5D).
01/03/2026 Comparative performance of virtual basket plus Magneto pulse modulations versus standard pulse holmium laser lithotripsy for urinary stones: A multicenter study
Socarrás, MER, Perri, D, Azabache, AK, Valle, J, Rico, L. Comparative performance of virtual basket plus Magneto pulse modulations versus standard pulse holmium laser lithotripsy for urinary stones: A multicenter study. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/02/2026 Ambient temperature and child nutritional status of more than 6 million children in Brazil: a cohort study
Ribeiro-Silva, RD, Luz, LP, Sacramento, LS, Cortes, TR, Ribeiro, LHL, Pepper, M, Delgado, D, Pescarini, JM, Rebouças, P, Silveira, IH, Costa, PRD, Ranzani, OT, Paixao, ES, Barreto, ML. Ambient temperature and child nutritional status of more than 6 million children in Brazil: a cohort study. Lancet Planetary Health. 2026; 10(2)DOI:10.1016/j.lanplh.2026.101428. PMID:41791402. IF:21.600(Q1/1D).
01/04/2026 High ambient temperature effects on the anthropometric status of the population: A systematic review and meta-analysis
Costa, PRD, Ribeiro-Silva, RD, Santos, RD, Magalhaes, KBBD, Cerqueira, ES, Rocha, AD, Luz, LP, Ribeiro, LHL, Ranzani, OT, Silveira, I, Pepper, M, Paixao, ES, Barreto, ML. High ambient temperature effects on the anthropometric status of the population: A systematic review and meta-analysis. PLoS One. 2026; 21(4)DOI:10.1371/journal.pone.0344186. PMID:41920813. IF:2.600(Q2/4D).
06/02/2026 Immune-mediated protection and enhancement of dengue drives patterns of infant cases in Brazil
Hitchings, MDT, Huang, AT, Ranzani, OT, García-Carreras, B, Nogueira, ML, Ko, AI, Croda, J, Salje, H, Cummings, DAT. Immune-mediated protection and enhancement of dengue drives patterns of infant cases in Brazil. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69111-x. PMID:41651817. IF:15.700(Q1/1D).
21/04/2026 Clarifying the SOFA-2 Score-Reply
Ranzani, OT, Singer, M, Moreno, RP. Clarifying the SOFA-2 Score-Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2026; 335(15)DOI:10.1001/jama.2026.0313. PMID:41837958. IF:55.000(Q1/1D).
12/08/2024 Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants
Furlano, M, Pilco-Teran, M, Pybus, M, Martínez, V, Aza-Carmona, M, Peris, AR, Pérez-Gomez, V, Berná, G, Mazon, J, Hernández, J, de Arizón, LF, Viera, E, Gich, I, Pérez, HV, Gomá-Garcés, E, Dolon, JLA, Ars, E, Torra, R. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae031. PMID:38317457. IF:5.600(Q1/1D).
01/01/2024 Improving the diagnosis of urinary tract infections by the use of enriched media and a 48-hour incubation period
Benjumea, C, Navarro, F, Tarrés, CA. Improving the diagnosis of urinary tract infections by the use of enriched media and a 48-hour incubation period. JOURNAL OF MEDICAL MICROBIOLOGY. 2024; 73(6)DOI:10.1099/jmm.0.001846. PMID:38935081. IF:2.000(Q3/8D).
01/03/2025 Breast radiotherapy planning: A decision-making framework using deep learning
Gallego, P, Ambroa, E, Pérezalija, J, Jornet, N, Anson, C, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A., Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. Breast radiotherapy planning: A decision-making framework using deep learning. MEDICAL PHYSICS. 2025; 52(3)DOI:10.1002/mp.17527. PMID:39625151. IF:3.200(Q1/3D).
01/01/2026 Opinion and Knowledge of Pulmonologists, Primary Care Physicians, and Nurses About Inhaled Therapy in COPD. Inhal-Epoc Survey
De Miguel-Díez, J, Donaire, JG, Sáenz, JTG, Carrero, JAT, Feliu, RA, Culebra, NC, Plaza, V. Opinion and Knowledge of Pulmonologists, Primary Care Physicians, and Nurses About Inhaled Therapy in COPD. Inhal-Epoc Survey. International Journal of Chronic Obstructive Pulmonary Disease. 2026; 21DOI:10.2147/COPD.S499279. PMID:41710326. IF:3.100(Q2/4D).
09/04/2026 Neurogenic cough in CANVAS syndrome: objective cough monitoring reveals a distinctive clinical pattern
Crespo-Lessmann, A, Bustamante, D, Vélez-Segovia, E, Najas, V, Palones, E. Neurogenic cough in CANVAS syndrome: objective cough monitoring reveals a distinctive clinical pattern. JOURNAL OF NEUROLOGY. 2026; 273(5)DOI:10.1007/s00415-026-13784-3. PMID:41954751. IF:4.600(Q1/2D).
01/01/2025 Influence of Outdoor Air Pollutants on Asthma: A Narrative Review.
Espejo, David, Plaza, Vicente, Quirce, Santiago, Trigueros, Juan Antonio, Munoz, Xavier. Influence of Outdoor Air Pollutants on Asthma: A Narrative Review.. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100448. PMID:. IF:(Q/D).
30/01/2025 Fenotipo hipersecretor en asma, diagnóstico e implicaciones
Crespo-Lessman, A, Vélez-Segovia, E, Sáez-Elizagaray, Javier. Fenotipo hipersecretor en asma, diagnóstico e implicaciones. Revista de Asma. 2025; 10(1)DOI:10.69703/asma.v10i1.2. PMID:. IF:(Q/D).
01/10/2022 Quality of interpersonal relations among emergency medical staff in Catalonia and differences in hospital and prehospital settings: a survey study
Jacob, J, Gene, E, Escalada, X, Villamor, A, Hernandez, R, Miro, O, Puig-Campmany M., ALONSO, GILBERTO. Quality of interpersonal relations among emergency medical staff in Catalonia and differences in hospital and prehospital settings: a survey study. EMERGENCIAS. 2022; 34(5)DOI:. PMID:36217936. IF:5.500(Q1/2D).
01/02/2025 Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas
Majercakova, K, Aguilar, NT, Verdum, JI, Bargallo, HV, Capel, AV, Soto, MM, Melcon, GGD, Cordero, JVR, Gonzalez-Lopez, JA, Rosell, SB, Jover, DH, Mitre, SR, Ibanez, AP, Sebio, A, Sancho-Pardo, G. Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas. Cancers. 2025; 17(4)DOI:10.3390/cancers17040624. PMID:40002219. IF:4.400(Q2/3D).
01/03/2024 Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group
Muñoz NG, Ortega S, Solanich X, Cid J, Díaz M, Moreno AB, Ancochea Á, Santos M, Hernández I, Sanchez JM, Luaña A, García J, Escoda L, Medina L, Ferrer GJ, López J, Céspedes R, Díaz JA, Pons V, Valcárcel D, Grifols JR. Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group. Blood Transfusion. 2024; 22(2)DOI:10.2450/BloodTransfus.522. PMID:37677097. IF:2.300(Q2/5D).
27/08/2024 Antibodies in Autoimmune Neuropathies
Pascual-Goñi, E, Caballero-avila, M, Querol, L. Antibodies in Autoimmune Neuropathies. NEUROLOGY. 2024; 103(4)DOI:10.1212/WNL.0000000000209725. PMID:39088795. IF:8.500(Q1/1D).
01/03/2024 Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?
Baeza, I, de la Serna, E, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, González-Pinto, A, Díaz-Caneja, CM, Corripio, I, Valli, I, Puig, O, Mané, A, Bioque, M, Ayora, M, Bernardo, M, Castro-Fornieles, J. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2024; 33(3)DOI:10.1007/s00787-023-02196-7. PMID:37027026. IF:4.900(Q1/1D).
03/09/2024 Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers
Fuentes-Claramonte, P, Estradé, A, Solanes, A, Ramella-Cravaro, V, Garcia-Leon, MA, de Diego-Adeliño, J, Molins, C, Fung, E, Valenti, M, Anmella, G, Pomarol-Clotet, E, Oliver, D, Vieta, E, Radua, J, Fusar-Poli, P. Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers. Schizophrenia Bulletin Open. 2024; 5(1)DOI:10.1093/schizbullopen/sgae018. PMID:39228676. IF:(Q/D).
01/10/2022 Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Delaby, C, Teunissen, CE, Blennow, K, Alcolea, D, Arisi, I, Amar, EB, Beaume, A, Bedel, A, Bellomo, G, Bigot-Corbel, E, Bjerke, M, Blanc-Quintin, MC, Boada, M, Bousiges, O, Chapman, MD, DeMarco, ML, D'Onofrio, M, Dumurgier, J, Dufour-Rainfray, D, Engelborghs, S, Esselmann, H, Fogli, A, Gabelle, A, Galloni, E, Gondolf, C, Grandhomme, F, Grau-Rivera, O, Hart, M, Ikeuchi, T, Jeromin, A, Kasuga, K, Keshavan, A, Khalil, M, Kortvelyessy, P, Kulczynska-Przybik, A, Laplanche, JL, Lewczuk, P, Li, QX, Lleo, A, Malaplate, C, Marquie, M, Masters, CL, Mroczko, B, Nogueira, L, Orellana, A, Otto, M, Oudart, JB, Paquet, C, Paoletti, FP, Parnetti, L, Perret-Liaudet, A, Peoc'h, K, Poesen, K, Puig-Pijoan, A, Quadrio, I, Quillard-Muraine, M, Rucheton, B, Schraen, S, Schott, JM, Shaw, LM, Suarez-Calvet, M, Tsolaki, M, Tumani, H, Udeh-Momoh, CT, Vaudran, L, Verbeek, MM, Verde, F, Vermunt, L, Vogelgsang, J, Wiltfang, J, Zetterberg, H, Lehmann, S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. ALZHEIMERS & DEMENTIA. 2022; 18(10)DOI:10.1002/alz.12545. PMID:34936194. IF:14.000(Q1/1D).
01/09/2021 Replication study of plasma proteins relating to Alzheimer's pathology
Shi, L, Winchester, LM, Westwood, S, Baird, AL, Anand, SN, Buckley, NJ, Hye, A, Ashton, NJ, Bos, I, Vos, SJB, ten Kate, M, Scheltens, P, Teunissen, CE, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, EE, Sleegers, K, Frisoni, GB, Blin, O, Richardson, JC, Bordet, R, Molinuevo, JL, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Freund-Levi, Y, Frolich, L, Dobricic, V, Legido-Quigley, C, Barkhof, F, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Lill, CM, Bertram, L, Visser, PJ, Kolb, HC, Narayan, VA, Lovestone, S, Nevado-Holgado, AJ. Replication study of plasma proteins relating to Alzheimer's pathology. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12322. PMID:33792144. IF:16.655(Q1/1D).
10/07/2024 Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study
Ulugut, H, Bertoux, M, Younes, K, Montembeault, M, Fumagalli, GG, Samanci, B, Illan-Gala, I, Kuchcinski, G, Leroy, M, Thompson, JC, Kobylecki, C, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R Jr, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Hansson, O, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Miller, BL, Scheltens, P, Ossenkoppele, R, van der Flier, WM, Barkhof, F, Fox, NC, Sturm, VE, Miyagawa, T, Whitwell, JL, Boeve, B, Rohrer, JD, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study. ALZHEIMERS & DEMENTIA. 2024; 20(8)DOI:10.1002/alz.14076. PMID:38982845. IF:11.100(Q1/1D).
03/06/2023 zZ Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research
Franzen, S, Nuytemans, K, Bourdage, R, Caramelli, P, Ellajosyula, R, Finger, E, Illan-Gala, I, Loi, SM, Morhardt, D, Pijnenburg, Y, Rascovsky, K, Williams, MM, Yokoyama, JS, Alladi, S, Ayhan, Y, Broce, I, Castro-Suarez, S, Coleman, K, de Souza, LC, Dacks, PA, de Boer, SCM, de Leon, J, Dodge, S, Grasso, S, Gupta, V, Gupta, V, Ghoshal, N, Kamath, V, Kumfor, F, Matias-Guiu, JA, Narme, P, Nielsen, TR, Okhuevbie, D, Pina-Escudero, SD, Garcia, RR, Scarioni, M, Slachevsky, A, Suarez-Gonzalez, A, Tee, BL, Tsoy, E, Ulugut, H, Babulal, GM, Onyike, CU. zZ Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research. ALZHEIMERS & DEMENTIA. 2023; 19(12)DOI:10.1002/alz.13129. PMID:37270665. IF:13.100(Q1/1D).
01/09/2024 Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090874. PMID:39335047. IF:4.600(Q1/2D).
08/08/2024 Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints
Grunden, N, Calabria, M, García-Sánchez, C, Pons, C, Arroyo, JA, Gómez-Ansón, B, Estévez-Garcia, MD, Belvís, R, Morollón, N, Cordero-Carcedo, M, Mur, I, Pomar, V, Domingo, P. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints. PLoS One. 2024; 19(8)DOI:10.1371/journal.pone.0302415. PMID:39116061. IF:2.600(Q2/4D).
01/04/2024 Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review
Lora-Tamayo, J, Mancheño-Losa, M, Meléndez-Carmona, MA, Hernández-Jiménez, P, Benito, N, Murillo, O. Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review. Antibiotics-Basel. 2024; 13(4)DOI:10.3390/antibiotics13040293. PMID:38666969. IF:4.600(Q1/2D).
01/03/2026 Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review
Calvo-Río, V, Secada-Gómez, C, Gutiérrez, AM, Retuerto-Guerrero, M, Font, J, Casafont-Solé, I, Mayo-Juanatey, A, Sancho, JJA, Freites, D, Hormigos, C, Puñal, NG, Arribas, GG, Sanchez, JRM, García-Valle, A, Ibañez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cortes-Hernandez, J, Sanchez, DP, Lojo, L, Pérez, ECC, Collado, P, Larios, CA, Icardo, LS, Labrador-Sánchez, E, Peralta-Ginés, C, Onaindia, IU, Plaza-Aulestia, N, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrián-Méndez, L, Pages, FAA, Riazuelo, JRL, Canales, MDF, Hernández, MJA, Bufort, MG, Pàmies, A, de Ardanaz, LS, Aguirre-del-Pino, R, Lefler, JAC, Seijas-Lopez, A, Cubero, MDC, Cofiño, ALC, Ortiz-Santamaria, V, Piñeiro, ML, Calvo, CO, Lopez, CA, Urruticoechea-Arana, A, Magallon, BG, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy-García, AM, Vilamajo, IR, Martos, AG, Lopez, BPM, Urmeneta, GS, Martín, CC, Riera, E, Bejerano, C, Castañeda, S, Blanco, R. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. RMD Open. 2026; 12(1)DOI:10.1136/rmdopen-2025-006549. PMID:41856562. IF:4.700(Q1/1D).
01/03/2026 B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
Agmon-Levin, N, Ignatenko, S, Gordienko, A, Cortés-Hernández, J, Narongroeknawin, P, Romanowska-Próchnicka, K, Shen, N, Ciferska, H, Kodera, M, Cheng-Chung, WJ, Leszczynski, P, Lan, JL, Mysler, E, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Lie, D, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, López, BPM, Ghanshani, SA, Lau, C, Avrameas, A, Sips, C, Oliver, SJ. B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(3)DOI:10.1016/j.ard.2025.11.015. PMID:41353079. IF:20.600(Q1/1D).
01/04/2026 The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)
Petelytska, L, Tofani, L, Velauthapillai, A, Dobrota, R, Becker, MO, Mihai, C, Muraru, S, Elhai, M, Jordan, S, Hachulla, E, Müller-Ladner, U, Siegert, E, Allanore, Y, Riemekasten, G, Bergmann, C, Becvar, R, Solanki, K, Anic, B, Szabo, I, Stamenkovic, B, Distler, J, Carreira, PE, Cuomo, G, Castellví, I, Balbir-Gurman, A, Airo, P, Litinsky, I, Saketkoo, LA, Bertaccini, B, Vonk, M, de Vries-Bouwstra, J, Hoffmann-Vold, AM, Matucci-Cerinic, M, Distler, O, Bruni, C. The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133). ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(4)DOI:10.1016/j.ard.2025.12.008. PMID:41549016. IF:20.600(Q1/1D).
01/03/2026 Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients
Loricera, J, Molina-Collada, J, Nieto, JC, Sánchez-Lucas, M, Silva-Díaz, MT, Moya, P, Labrador, E, Ferraz-Amaro, I, Blanco, R. Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients. DRUGS & AGING. 2026; 43(3)DOI:10.1007/s40266-026-01281-1. PMID:41714460. IF:3.800(Q2/3D).
01/04/2026 Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study
Corominas, H, Guigini, MA, Ameruso, YS, Reina, D. Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study. CURRENT MEDICAL RESEARCH AND OPINION. 2026; 42(2)DOI:10.1080/03007995.2026.2656544. PMID:42030169. IF:2.200(Q2/3D).
01/06/2024 Allergy to Theobroma Cacao
Valencia, AN, Retes, LS, Bartolomé-Zavala, B, Gutiérrez, GP, Bigorra, T. Allergy to Theobroma Cacao. Clinical Case Reports. 2024; 12(6)DOI:10.1002/ccr3.8803. PMID:38883222. IF:(Q/D).
05/01/2024 Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
del Pozo, V, Bobolea, I, Rial, MJ, Espigol-Frigolé, G, Laqué, RS, Hernández-Rivas, JM, Mora, E, Crespo-Lessmann, A, Alonso, JLI, Sosa, MSD, Maza-Solano, J, Atienza-Mateo, B, Bañas-Conejero, D, Moure, AL, Rúa-Figueroa, I. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Frontiers in Immunology. 2024; 14DOI:10.3389/fimmu.2023.1310211. PMID:38250075. IF:5.900(Q1/2D).
01/02/2024 Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function
Quesada-López, T, Cereijo, R, Blasco-Roset, A, Mestres-Arenas, A, Prieto, P, Domingo, JC, Villarroya, F, Domingo, P, Giralt, M. Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function. BIOCHEMICAL PHARMACOLOGY. 2024; 220DOI:10.1016/j.bcp.2023.116010. PMID:38154544. IF:5.600(Q1/1D).
01/08/2024 BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC
Provencio, M, de Lope, LR, Serna-Blasco, R, Nadal, E, Tain, PD, Massuti, B, González-Larriba, JL, Insa, A, Sánchez-Hernández, A, Casal-Rubio, J, Garcia-Campelo, R, López, SS, Rogado, J, Martínez-Martí, A, Bosch-Barrera, J, Bernabé, R, Estévez, SV, Ponce, S, de Castro, J, Sarto, JC, Reguart, N, Dómine, M, Aguilar, A, Majem, M, Estival, A, Cabia, SP, Martín, AL, González, MAS, Cobo, M, Camps, C, Barneto, I, Calvo, V, Collazo-Lorduy, A, Cruz-Bermúdez, A, Romero, A. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC. LUNG CANCER. 2024; 194DOI:10.1016/j.lungcan.2024.107865. PMID:38945004. IF:4.400(Q1/2D).
01/07/2025 Impact of Alzheimer's disease on sleep in adults with Down syndrome
Giménez, S, Vaqué-Alcázar, L, Zhu, NL, Benejam, B, Arranz, J, Maure-Blesa, L, Videla, L, Carmona-Iragui, M, Barroeta, I, Rebillat, AS, Rodriguez-Baz, I, Bejanin, A, Arriola-Infante, JE, Bueno, A, Fernandez, S, Ribas, L, Zsadanyi, SE, Morcillo-Nieto, AO, Alcolea, D, Lisgaras, CP, Blessing, E, Osorio, RS, Lleo, A, Fortea, J. Impact of Alzheimer's disease on sleep in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70400. PMID:40604343. IF:11.100(Q1/1D).
01/02/2026 Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study
Buchmeier, EL, Reck, M, Girard, N, Nadal, E, Gay, CM, Filippi, AR, Martin, LW, Petersen, C, Cairns, DA, Roch, B, Attili, I, Alvarez, RA, Boyer, A, Tarruella, MM, Robinson, A, Levra, MG, Li, L, Perez, ID, Georgoulia, N, Spicer, J. Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026 International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
Giani, C, Baldi, GG, Ljevar, S, Denu, RA, Andelkovic, V, Han, I, Brunello, A, Napolitano, A, Bhadri, VA, Scanferla, R, Garcia, AS, Abreu, MH, Campos, F, Ogura, K, Wong, DD, Bae, S, Marquina, G, Mazzocca, A, Yang, V, Nakazawa, MS, Kim, HS, Chiusole, B, Thway, K, Antonescu, C, Bellan, E, Bovée, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Chen, TWW, Miceli, R, Gronchi, A, Stacchiotti, S. International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease. ESMO Open. 2026; 11(2)DOI:10.1016/j.esmoop.2025.106044. PMID:41564817. IF:8.300(Q1/2D).
01/02/2026 IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC
Christoph, D, Paz-Ares, L, Borghaei, H, Liu, S, Peters, S, Herbst, R, Stencel, K, Tarruella, MM, Czyzewicz, G, Caro, RB, Lee, KH, Johnson, ML, Karadurmus, N, Grohé, C, Cuchelkar, V, Graupner, V, Kaul, M, Lin, YC, Chakrabarti, D, Bhatt, K, Reck, M. IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/01/2026 Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)
López-Tarruella, S, Guerrero-Zotano, A, Antolín, S, Cruz, J, Martínez, P, Rodríguez, CA, Falo, C, Rodríguez-Lescure, A, Adrover, E, Hernández, M, Andrés, R, Chacón, JI, Romero, JLA, Miguel, A, Gómez-Raposo, C, Margelí, M, González, I, Guerra, JA, Antón, A, Tibau, A, Miralles, JJ, Escudero, MJ, Bezares, S, Rojo, F, Alvarez, I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Therapeutic Advances in Medical Oncology. 2026; 18DOI:10.1177/17588359261421813. PMID:41732657. IF:4.200(Q2/3D).